{"id":22359,"date":"2025-01-21T08:51:00","date_gmt":"2025-01-21T08:51:00","guid":{"rendered":"https:\/\/www.nordicbioscience.com\/?p=22359"},"modified":"2025-08-26T12:31:38","modified_gmt":"2025-08-26T12:31:38","slug":"tau-and-type-iv-collagen-fragments-as-serum-biomarkers-in-recurrent-glioblastoma","status":"publish","type":"post","link":"https:\/\/www.nordicbioscience.com\/blog\/tau-and-type-iv-collagen-fragments-as-serum-biomarkers-in-recurrent-glioblastoma\/","title":{"rendered":"Tau and Type IV Collagen Fragments as Serum Biomarkers in Recurrent Glioblastoma"},"content":{"rendered":"\n

Glioblastoma (GBM) remains a devastating disease with limited treatment options and a lack of reliable, non-invasive biomarkers to guide therapy and predict outcomes.<\/p>\n\n\n

\n
\"\"
Tau-A and C4G offer a potential value in patients with glioblastoma <\/em><\/figcaption><\/figure><\/div>\n\n\n

In this study, we identify serum biomarkers (Tau-A<\/a> and C4G<\/a>) that are significantly elevated in patients with recurrent GBM and that show a strong association with improved overall survival (OS) when treated with nivolumab and bevacizumab. Unlike conventional imaging or invasive methods, these serum biomarkers provide a non-invasive, dynamic, and easily accessible approach to track disease progression and response to treatment.

Tau-A and C4G offer a potential tool to stratify patients, monitor treatment efficacy, and predict survival outcomes in GBM, addressing a critical gap in current clinical practice.

We therefore encourage clinicians and researchers to explore the validation and integration of Tau-A<\/a> and C4G<\/a> into clinical trials and routine practice to unlock new possibilities in personalized GBM management.

Article: Degradation fragments of Tau and type IV collagen as serum biomarkers in patients with recurrent glioblastoma treated with nivolumab and bevacizumab<\/em><\/p>\n\n\n\n

\n
Find the article here<\/a><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Glioblastoma (GBM) remains a devastating disease with limited treatment options and a lack of reliable, non-invasive biomarkers to guide therapy and predict outcomes. In this study, we identify serum biomarkers (Tau-A and C4G) that are significantly elevated in patients with recurrent GBM and that show a strong association with improved overall survival (OS) when treated […]<\/p>\n","protected":false},"author":4,"featured_media":22360,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[5191],"tags":[],"class_list":["post-22359","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-2-minute-science"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.nordicbioscience.com\/wp-json\/wp\/v2\/posts\/22359","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nordicbioscience.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nordicbioscience.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nordicbioscience.com\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nordicbioscience.com\/wp-json\/wp\/v2\/comments?post=22359"}],"version-history":[{"count":5,"href":"https:\/\/www.nordicbioscience.com\/wp-json\/wp\/v2\/posts\/22359\/revisions"}],"predecessor-version":[{"id":28168,"href":"https:\/\/www.nordicbioscience.com\/wp-json\/wp\/v2\/posts\/22359\/revisions\/28168"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nordicbioscience.com\/wp-json\/wp\/v2\/media\/22360"}],"wp:attachment":[{"href":"https:\/\/www.nordicbioscience.com\/wp-json\/wp\/v2\/media?parent=22359"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nordicbioscience.com\/wp-json\/wp\/v2\/categories?post=22359"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nordicbioscience.com\/wp-json\/wp\/v2\/tags?post=22359"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}